Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $96.81 billion as of April 19, 2024. Its market cap has increased by 6.64% in one year.

• Market Cap: 96.81B
• Enterprise Value: 88.66B
• 1-Year Change: 6.64%
• Ranking: #123
• Category: Large-Cap
• Stock Price: $896.82

Market Cap Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $96.81B, an increase of 38,315.21%. That is a compound annual growth rate of 26.40%.

Market Cap History

Date	Market Cap	% Change
Apr 19, 2024	98.44B	0.32%
Apr 18, 2024	98.13B	-0.80%
Apr 17, 2024	98.92B	0.79%
Apr 16, 2024	98.14B	-0.49%
Apr 15, 2024	98.63B	-0.68%
Apr 12, 2024	99.30B	-1.70%
Apr 11, 2024	101.02B	-1.70%
Apr 10, 2024	102.76B	-0.81%
Apr 9, 2024	103.60B	0.58%
Apr 8, 2024	103.01B	-0.45%
Apr 5, 2024	103.47B	0.61%
Apr 4, 2024	102.85B	-1.46%
Apr 3, 2024	104.38B	-0.39%
Apr 2, 2024	104.79B	-1.51%
Apr 1, 2024	106.39B	0.71%
Mar 28, 2024	105.64B	-0.39%
Mar 27, 2024	106.06B	0.29%
Mar 26, 2024	105.76B	0.26%
Mar 25, 2024	105.49B	-0.64%
Mar 22, 2024	106.17B	-0.08%
Mar 21, 2024	106.25B	0.11%
Mar 20, 2024	106.14B	0.34%
Mar 19, 2024	105.77B	0.39%
Mar 18, 2024	105.36B	-0.47%
Mar 15, 2024	105.86B	0.57%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Sanofi	107.84B
Medtronic	105.00B
Vertex Pharmaceuticals	101.54B
Boston Scientific	99.89B
Cigna	98.16B
Bristol-Myers Squibb Company	96.96B
CVS Health	86.33B
Gilead Sciences	83.46B